Evaluation of the Efficacy and Safety of Risperidone Injections Given Once a Month to Adults With Schizophrenia or Schizoaffective Disorder
Clinical trial NCT00236353 · COMPLETED
Trial details
- NCT number
- NCT00236353
- Sponsor
- Janssen, LP
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2002-05-01
- Enrollment
- 86
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.